Nanjing Medlander Medical Technology Co. Ltd. A Market Cap ($381.19 Million)
Market Cap & Net Worth: Nanjing Medlander Medical Technology Co. Ltd. A (688273)
Nanjing Medlander Medical Technology Co. Ltd. A market cap. Nanjing Medlander Medical Technology Co. Ltd. A (SHG:688273) has a market capitalization of $381.19 Million (CN¥2.60 Billion) as of October 18, 2026. Listed on the SHG stock exchange, this China-based company holds position #13634 globally and #4064 in its home market, demonstrating a -7.92% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Nanjing Medlander Medical Technology Co. Ltd. A's stock price CN¥26.05 by its total outstanding shares 100000000 (100.00 Million).
Nanjing Medlander Medical Technology Co. Ltd. A Market Cap History (2022–2026)
Nanjing Medlander Medical Technology Co. Ltd. A market cap history from 2022 to 2026. Data shows change from $446.93 Million to $381.19 Million (-10.11% CAGR). Check Nanjing Medlander Medical Technology Co. share price for real-time trading data and today's change.
Nanjing Medlander Medical Technology Co. Ltd. A Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Nanjing Medlander Medical Technology Co. Ltd. A's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Also see cash efficiency ratio of Nanjing Medlander Medical Technology Co. for how efficiently the company converts equity into cash flow.
Latest Price to Sales (P/S) Ratio
0.81x
Nanjing Medlander Medical Technology Co. Ltd. A's market cap is 0.81 times its annual revenue
Latest Price to Earnings (P/E) Ratio
3.37x
Nanjing Medlander Medical Technology Co. Ltd. A's market cap is 3.37 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $446.93 Million | $376.89 Million | $121.68 Million | 1.19x | 3.67x |
| 2023 | $465.66 Million | $340.82 Million | $89.82 Million | 1.37x | 5.18x |
| 2024 | $341.98 Million | $424.55 Million | $101.58 Million | 0.81x | 3.37x |
Competitor Companies of 688273 by Market Capitalization
Companies near Nanjing Medlander Medical Technology Co. Ltd. A in the global market cap rankings as of October 18, 2026. See how leveraged is Nanjing Medlander Medical Technology Co.'s balance sheet to understand what proportion of total assets are financed by equity.
Key companies related to Nanjing Medlander Medical Technology Co. Ltd. A by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #118 globally with a market cap of $182.39 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #220 globally with a market cap of $113.02 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #230 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #241 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #118 | Abbott Laboratories | NYSE:ABT | $182.39 Billion | $104.89 |
| #220 | Stryker Corporation | NYSE:SYK | $113.02 Billion | $294.66 |
| #230 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $94.75 |
| #241 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Nanjing Medlander Medical Technology Co. Ltd. A (2022–2026)
Market capitalization of Nanjing Medlander Medical Technology Co. Ltd. A from 2022 to today. Between 2022 and today, Nanjing Medlander Medical Technology Co. Ltd. A's market cap moved from $446.93 Million to $ 381.19 Million, with a yearly change of -10.11%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥381.19 Million | -38.73% |
| 2025 | CN¥622.20 Million | +81.94% |
| 2024 | CN¥341.98 Million | -26.56% |
| 2023 | CN¥465.66 Million | +4.19% |
| 2022 | CN¥446.93 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 17th, 2026 the market cap of Nanjing Medlander Medical Technology Co. Ltd. A was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $381.19 Million USD |
| MoneyControl | $381.19 Million USD |
| MarketWatch | $381.19 Million USD |
| marketcap.company | $381.19 Million USD |
| Reuters | $381.19 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Nanjing Medlander Medical Technology Co. Ltd. A
Nanjing Medlander Medical Technology Co.,Ltd. engages in the research and development, manufacture, sale, and service of pelvic floor rehabilitation equipment and related products in China and internationally. It offers pelvic floor and obstetrics and gynecology rehabilitation, reproductive rehabilitation product, and sports rehabilitation products, as well as consumables products, such as vagina… Read more